We are live on ! Find out more
APYX icon

Apyx Medical
APYX

23 hedge funds and large institutions have $4.56M invested in Apyx Medical in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

28% more funds holding

Funds holding: 18 → 23 (+5)

25% more capital invested

Capital invested by funds: $3.64M → $4.56M (+$922K)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

Holders
23
Holders Change
+5
Holders Change %
+27.78%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$869K
2
VKH
Virtu KCG Holdings
New York
+$65.4K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$62.4K
4
First Manhattan
First Manhattan
New York
+$56.6K
5
BIM
BlackRock Investment Management
Delaware
+$11.7K

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$96K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$10.1K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$5.7K
4
Northern Trust
Northern Trust
Illinois
-$748
5
GC
Globeflex Capital
California
-$291

APYX Hedge Fund Activity: Q2 2014 in Review

23 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2014, worth a combined $4.56M — up 25% from $3.64M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new APYX positions and 1 closed out — a net gain of 5 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $869K. The largest seller was UBS AM, exiting entirely with an estimated $96K sold.

  • 23 institutional investors held Apyx Medical (APYX) as of Q2 2014, up from 18 in Q1 2014.
  • Funds reported $4.56M of Apyx Medical stock for Q2 2014, up 25% quarter-over-quarter.
  • 6 funds opened new Apyx Medical positions in Q2 2014 and 1 closed out, a net change of +5 holders.
  • The largest Apyx Medical buyer in Q2 2014 was Millennium Management, an estimated $869K added.
  • The largest Apyx Medical seller in Q2 2014 was UBS AM, an estimated $96K sold.

Based on aggregated 13F filings for Q2 2014.